BNP Paribas Financial Markets’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $493K | Sell |
27,447
-367,646
| -93% | -$5.14M | ﹤0.01% | 3769 |
|
|
2026
Q1 | $3.72M | Buy |
395,093
+38,289
| +11% | +$420K | ﹤0.01% | 2244 |
|
|
2025
Q4 | $4.43M | Buy |
356,804
+57,823
| +19% | +$769K | ﹤0.01% | 2127 |
|
|
2025
Q3 | $4.28M | Buy |
298,981
+224,891
| +304% | +$3.08M | ﹤0.01% | 2084 |
|
|
2025
Q2 | $909K | Buy |
74,090
+64,523
| +674% | +$937K | ﹤0.01% | 2972 |
|
|
2025
Q1 | $210K | Sell |
9,567
-5,123
| -35% | -$120K | ﹤0.01% | 3663 |
|
|
2024
Q4 | $333K | Sell |
14,690
-97,085
| -87% | -$2.12M | ﹤0.01% | 3559 |
|
|
2024
Q3 | $2.03M | Buy |
111,775
+99,685
| +825% | +$2.31M | ﹤0.01% | 2031 |
|
|
2024
Q2 | $352K | Sell |
12,090
-2,933
| -20% | -$87K | ﹤0.01% | 2837 |
|
|
2024
Q1 | $533K | Buy |
15,023
+7,340
| +96% | +$294K | ﹤0.01% | 2805 |
|
|
2023
Q4 | $335K | Sell |
7,683
-7,639
| -50% | -$301K | ﹤0.01% | 3018 |
|
|
2023
Q3 | $585K | Buy |
15,322
+3,710
| +32% | +$156K | ﹤0.01% | 2637 |
|
|
2023
Q2 | $478K | Sell |
11,612
-3,281
| -22% | -$158K | ﹤0.01% | 2606 |
|
|
2023
Q1 | $855K | Sell |
14,893
-32,182
| -68% | -$1.81M | ﹤0.01% | 2421 |
|
|
2022
Q4 | $2.64M | Buy |
+47,075
| New | +$2.4M | ﹤0.01% | 1615 |
|
|
2022
Q3 | – | Sell |
-45,338
| Closed | -$2.45M | – | 4866 |
|
|
2022
Q2 | $2.45M | Sell |
45,338
-25,133
| -36% | -$1.51M | ﹤0.01% | 1637 |
|
|
2022
Q1 | $4.53M | Sell |
70,471
-13,115
| -16% | -$863K | 0.01% | 1346 |
|
|
2021
Q4 | $5.6M | Buy |
83,586
+63,885
| +324% | +$4.32M | 0.01% | 1283 |
|
|
2021
Q3 | $1.35M | Buy |
19,701
+7,702
| +64% | +$544K | ﹤0.01% | 2175 |
|
|
2021
Q2 | $819K | Buy |
11,999
+1,732
| +17% | +$122K | ﹤0.01% | 2291 |
|
|
2021
Q1 | $709K | Buy |
10,267
+4,200
| +69% | +$285K | ﹤0.01% | 2355 |
|
|
2020
Q4 | $394K | Buy |
6,067
+220
| +4% | +$11.8K | ﹤0.01% | 2579 |
|
|
2020
Q3 | $276K | Sell |
5,847
-33,299
| -85% | -$1.58M | ﹤0.01% | 2574 |
|
|
2020
Q2 | $1.84M | Sell |
39,146
-35,062
| -47% | -$1.72M | ﹤0.01% | 1531 |
|
|
2020
Q1 | $3.31M | Buy |
74,208
+67,269
| +969% | +$3.53M | 0.01% | 1206 |
|
|
2019
Q4 | $404K | Sell |
6,939
-4,259
| -38% | -$254K | ﹤0.01% | 2581 |
|
|
2019
Q3 | $673K | Buy |
11,198
+9,877
| +748% | +$588K | ﹤0.01% | 2045 |
|
|
2019
Q2 | $73.8K | Sell |
1,321
-999
| -43% | -$51.4K | ﹤0.01% | 3206 |
|
|
2019
Q1 | $129K | Buy |
2,320
+1,266
| +120% | +$64.5K | ﹤0.01% | 2969 |
|
|
2018
Q4 | $47.5K | Sell |
1,054
-6,219
| -86% | -$341K | ﹤0.01% | 2729 |
|
|
2018
Q3 | $479K | Buy |
7,273
+829
| +13% | +$51.5K | ﹤0.01% | 2043 |
|
|
2018
Q2 | $415K | Sell |
6,444
-14,410
| -69% | -$892K | ﹤0.01% | 2090 |
|
|
2018
Q1 | $1.15M | Sell |
20,854
-5,564
| -21% | -$292K | ﹤0.01% | 1642 |
|
|
2017
Q4 | $1.26M | Sell |
26,418
-6,409
| -20% | -$314K | ﹤0.01% | 1802 |
|
|
2017
Q3 | $1.66M | Sell |
32,827
-118,154
| -78% | -$6.07M | ﹤0.01% | 1235 |
|
|
2017
Q2 | $8.23M | Buy |
150,981
+63,200
| +72% | +$3.02M | 0.02% | 583 |
|
|
2017
Q1 | $3.7M | Buy |
87,781
+74,345
| +553% | +$3.18M | 0.01% | 857 |
|
|
2016
Q4 | $576K | Sell |
13,436
-319,068
| -96% | -$13M | ﹤0.01% | 1620 |
|
|
2016
Q3 | $13.7M | Sell |
332,504
-28,350
| -8% | -$1.19M | 0.06% | 232 |
|
|
2016
Q2 | $14.4M | Sell |
360,854
-51,526
| -12% | -$1.85M | 0.06% | 218 |
|
|
2016
Q1 | $13.9M | Buy |
412,380
+73,662
| +22% | +$2.29M | 0.06% | 276 |
|
|
2015
Q4 | $11.5M | Sell |
338,718
-51,592
| -13% | -$1.61M | 0.06% | 268 |
|
|
2015
Q3 | $11.6M | Sell |
390,310
-136,149
| -26% | -$4.26M | 0.03% | 389 |
|
|
2015
Q2 | $14.5M | Buy |
526,459
+8,800
| +2% | +$235K | 0.04% | 257 |
|
|
2015
Q1 | $13M | Buy |
517,659
+105,301
| +26% | +$2.49M | 0.04% | 327 |
|
|
2014
Q4 | $9.14M | Buy |
412,358
+60,861
| +17% | +$1.23M | 0.03% | 463 |
|
|
2014
Q3 | $7.13M | Buy |
351,497
+103,400
| +42% | +$2.06M | 0.01% | 616 |
|
|
2014
Q2 | $4.77M | Buy |
248,097
+245,651
| +10,043% | +$4.58M | ﹤0.01% | 676 |
|
|
2014
Q1 | $45.6K | Sell |
2,446
-715
| -23% | -$13.8K | ﹤0.01% | 2141 |
|
|
2013
Q4 | $61.6K | Sell |
3,161
-15,493
| -83% | -$284K | ﹤0.01% | 1832 |
|
|
2013
Q3 | $307K | Buy |
18,654
+1,470
| +9% | +$23.6K | ﹤0.01% | 1902 |
|
|
2013
Q2 | $257K | Buy |
+17,184
| New | +$252K | ﹤0.01% | 2128 |
|
Other funds holding IART
RCMNY
PCMI
BNP Paribas Financial Markets's IART Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Integra LifeSciences (IART) stake by 93% in Q2 2026, selling an estimated $5.14M and leaving 27,447 shares worth $493K. The position accounts for ﹤0.01% of the portfolio, ranked #3769.
BNP Paribas Financial Markets first reported a position in IART in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.5M in Q2 2015. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- BNP Paribas Financial Markets held 27,447 shares of Integra LifeSciences worth $493K as of Q2 2026.
- BNP Paribas Financial Markets sold 367,646 Integra LifeSciences shares in Q2 2026, an estimated $5.14M.
- Integra LifeSciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3769 holding.
- BNP Paribas Financial Markets first reported a position in Integra LifeSciences in Q2 2013 and has held it in 52 quarters since.
- BNP Paribas Financial Markets's Integra LifeSciences position peaked at $14.5M in Q2 2015.
- 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.